English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Register Now: iCMLf Regional Discussion Groups - Latin America 2025
We are pleased to announce the first instalment of our 2025 Latin American regional program to address specific local challenges for physicians treating people with CML. We are starting this year's progam of three zoom-based Regional Discussion Groups on May 8th.
iCMLf Launches Climb for a Cure 2026: Conquer the Avenue of Volcanoes to Transform CML Care
Are you ready for an unforgettable adventure that makes a difference?
Building on the success of Climb for a Cure: Kilimanjaro (2019) and Annapurna (2023) - which together raised over $500,000 for CML research - the iCMLf is thrilled to announce the next chapter: Climb for a Cure 2026.
In February 2026, we will take on the Avenue of Volcanoes in Ecuador - a breathtaking high-altitude challenge through one of the most stunning landscapes in the world. Over seven days, participants will trek through Cotopaxi National Park, climb to awe-inspiring viewpoints, and push their limits alongside a passionate team of researchers, doctors, patients, and CML advocates - all united by a single goal: drive progress in CML research, treatment, and patient care.
Share your experiences - Hepatitis B and CML survey open until February 27th
Febuary 2025 - It’s still time to share your experiences in the iCMLf Hepatitis B Virus (HBV) and CML Screening and Management Survey. Your input is invaluable, and we look forward to learning from your clinical practice.
This survey is a key initiative to address the risk of HBV reactivation in CML patients receiving TKI therapy. Since there are currently no comprehensive guidelines and recommendations on HBV screening and monitoring for CML patients on TKIs, the data collected will help bridge this gap and inform future recommendations.
Submissions are welcome until February 27th, 2025.
World Cancer Day 2025: Living with CML, Not Defined by It
This World Cancer Day, we spoke to Darshana Ramesh, who was diagnosed with chronic myeloid leukemia in 2021. Her journey - from an unexpected diagnosis in a foreign country to finding the right treatment and understanding her new reality - highlights both the incredible progress in CML care and the challenges that still remain. We spoke to Darshana from her home in Singapore.
Celebrating 25 Years of TKIs: A Legacy of Hope and Progress
2025 is a remarkable milestone in the fight against chronic myeloid leukemia - the 25th anniversary of tyrosine kinase inhibitors (TKIs). The story of TKI development is one of collaboration and courage. A story that formed the basis of the iCMLf, and one that we hope to emulate as we continue working to improve outcomes for people with CML.
Over the coming year we will share highlights of the development, impact and future opportunities of this incredible therapy. To begin, we share a message from Professor Jorge Cortes and Professor Brian Druker.
Reminder: Call for iCMLf Prize nominations - Submission deadline January 31
January 2025 - There is still time to recognise outstanding contributions to CML research and patient management with one of the three 2025 iCMLf Prizes:
🥇 The Rowley Prize – For groundbreaking contributions to CML biology.
🥇 The Goldman Prize – Recognising transformative advancements in CML patient care.
🥇 The iCMLf Prize – Highlighting exceptional efforts to overcome CML treatment challenges in low- and middle-income countries.
Submit your nominations by January 31st
